WHO updates policy on collaborative TB/HIV activities
WHO has updated its policy on collaborative tuberculosis (TB)/HIV activities. The new policy guidelines are revising the previous TB/HIV interim policy published in 2004 and are based on the new evidence generated from research.
These guidelines are particularly welcome in the European Region, where TB is a leading cause of death among people living with HIV (PLHIV) and where there are the highest rates of multidrug-resistant TB. While coverage of HIV testing for TB patients is particularly high - 80% of TB patients know their HIV status – antiretroviral therapy (ART) coverage among people with TB/HIV co-infection remains insufficient and access to isoniazid preventive therapy for latent TB infection among PLHIV is low.
WHO/Europe, as part of its ongoing work to revise region-specific clinical protocols on HIV/AIDS treatment and care originally published in 2007 is updating its own guidance on the management of TB/HIV co-infection.